Looker Benjamin - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)

Updated on January 3, 2026.

According to recent SEC insider information filed on Dec 17, 2025, Looker Benjamin's relationship to Esperion Therapeutics, Inc. (ESPR) is Officer (General Counsel), and currently has 385,905 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other ESPR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Looker Benjamin - Insider Non-Derivative Transactions of ESPR Common Stock

Looker Benjamin - Insider Non-Derivative Transactions at ESPR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 18, 2025	Sell -- (Common Stock)	6517	3.67	385905
Oct 18, 2025	Sell -- (Common Stock)	1248	2.62	392422
Sep 18, 2025	Sell -- (Common Stock)	6267	2.8	393670
Jul 18, 2025	Sell -- (Common Stock)	1304	1.13	399937
Jun 18, 2025	Sell -- (Common Stock)	6422	1.15	401241
Mar 15, 2025	Acquisition -- (Common Stock)	224000	0	407663
Mar 15, 2024	Acquisition -- (Common Stock)	100000	0	183663
Apr 20, 2023	Sell -- (Common Stock)	1290	1.27	83663
Mar 15, 2023	Acquisition -- (Common Stock)	20500	0	84953
Jan 19, 2023	Sell -- (Common Stock)	6347	7	64453